ARTICLE | Clinical News
Celtura: Phase I data
January 4, 2010 8:00 AM UTC
Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Product: Celtura Business: Infectious Molecular target: Not applicable Description: MF59-adjuvanted cell culture-based swine influenza A (H1N1) va...